GlassScriptPhysician profile
Deepika Satish
NPI 1336501899
$5,433.43
in general payments reported to CMS, 2019-2025
13 companies · $465 in 2025
The $465 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,465 · 2023: $1,673 · 2024: $1,831 · 2025: $465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,382 · Travel and Lodging: $1,586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,382.43 |
| Travel and Lodging | $1,586.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,442.07 | 2022-2025 | Apollo Esg Nxt System, Apollo Esg System, Overstitch Endoscopic Suturing System |
| Conmed Corporation | $331.20 | 2023-2025 | Conmed Generators, Conmed Biliary |
| Abbvie INC. | $181.94 | 2023-2024 | Viberzi, Linzess |
| Takeda Pharmaceuticals U.S.A., INC. | $111.59 | 2024 | Entyvio, Gattex |
| Madrigal Pharmaceuticals | $103.74 | 2024-2025 | Rezdiffra, Resmetirom |
| Fujifilm Healthcare Americas Corporation | $75.00 | 2023 | |
| Intercept Pharmaceuticals, INC. | $34.75 | 2024 | |
| Enterra Medical, INC. | $33.49 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.05 | 2024 | Xifaxan |
| Merck Sharp & Dohme LLC | $27.52 | 2023 | Dificid |
| Regeneron Healthcare Solutions, INC. | $23.71 | 2025 | Dupixent |
| Celltrion USA INC. | $18.40 | 2025 | Vegzelma |
| Janssen Biotech, INC. | $17.97 | 2025 | Tremfya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepika Satish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.